NCT00086047

Brief Summary

Juvenile fibromyalgia is a chronic pain condition that can cause considerable suffering and difficulty in an adolescent's day-to-day activities. The purpose of this study is to determine whether coping skills training, when combined with usual medical care, can reduce pain and disability in adolescents with fibromyalgia. Study hypotheses: 1) Adolescents who receive coping skills training combined with their usual medical care will show significantly greater reductions in functional disability, pain, and depressive symptoms at the end of the acute treatment phase than adolescents who receive fibromyalgia education with their usual medical care. 2) Adolescents who receive coping skills training with their usual medical care will show significantly lower levels of functional disability, pain, and depressive symptoms at the end of a six-month maintenance phase than adolescents who receive fibromyalgia education with their usual medical care.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
114

participants targeted

Target at P25-P50 for phase_3

Timeline
Completed

Started Jul 2004

Longer than P75 for phase_3

Geographic Reach
1 country

3 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 22, 2004

Completed
1 day until next milestone

First Posted

Study publicly available on registry

June 23, 2004

Completed
8 days until next milestone

Study Start

First participant enrolled

July 1, 2004

Completed
6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2010

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2010

Completed
3.4 years until next milestone

Results Posted

Study results publicly available

November 6, 2013

Completed
Last Updated

September 20, 2017

Status Verified

August 1, 2017

Enrollment Period

6 years

First QC Date

June 22, 2004

Results QC Date

August 12, 2011

Last Update Submit

August 23, 2017

Conditions

Keywords

Juvenile Fibromyalgia SyndromeJPFSFibromyalgiaChronic PainPediatric PainJuvenile Fibromyalgia

Outcome Measures

Primary Outcomes (1)

  • Change in FDI (Functional Disability Inventory) Scores at End of Study

    Functional disability score is measured by the Functional Disability Inventory (FDI)which assesses ability to engage in usual physical, social and recreational activities. Scores range from 0=no disability to 60 = extreme disability and and are interpreted as No/Mild disability (0-12); Moderate Disability (13-29) and Severe Disability (30-60)

    Baseline and 6 months (end of study)

Secondary Outcomes (2)

  • Pain Intensity

    9 weeks and 6 months

  • Depressive Symptoms

    9 weeks and 6 months

Study Arms (2)

Coping Skills

EXPERIMENTAL

Patients will receive 8 weeks of behavioral training in pain coping strategies

Behavioral: Coping Skills Training

Education

ACTIVE COMPARATOR

Patient will receive 8 weekly sessions of education about fibromyalgia syndrome.

Behavioral: Education

Interventions

8 weekly sessions of behavioral treatment

Also known as: cognitive-behavioral therapy
Coping Skills
EducationBEHAVIORAL

8 weekly sessions of fibromyalgia education

Education

Eligibility Criteria

Age11 Years - 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Diagnosis of JPFS based upon widespread pain for over 3 months, at least 5 tender points, and associated features such as sleep difficulty, fatigue, and abdominal discomfort
  • Average pain intensity greater than 4 on the Visual Analog Scale
  • Functional disability score greater than 7
  • Stable medications for 8 weeks prior to study entry

You may not qualify if:

  • Other chronic rheumatic diseases, such as juvenile rheumatoid arthritis or lupus
  • Significant developmental delay or impairments, such as autism, cerebral palsy, or mental retardation
  • Present or lifetime psychiatric diagnosis that meets DSM-IV criteria for panic disorder, bipolar disorder, major depressive disorder, or psychosis
  • Opioid medications are disallowed when used on an ongoing basis for treatment of fibromyalgia pain

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

Kosair Charities Pediatric Center

Louisville, Kentucky, 40202, United States

Location

Cincinnati Children's Hospital Medical Center

Cincinnati, Ohio, 45229, United States

Location

Cleveland Clinic Foundation, Division of Pediatrics

Cleveland, Ohio, 44195, United States

Location

Related Publications (2)

  • Kashikar-Zuck S, Ting TV, Arnold LM, Bean J, Powers SW, Graham TB, Passo MH, Schikler KN, Hashkes PJ, Spalding S, Lynch-Jordan AM, Banez G, Richards MM, Lovell DJ. Cognitive behavioral therapy for the treatment of juvenile fibromyalgia: a multisite, single-blind, randomized, controlled clinical trial. Arthritis Rheum. 2012 Jan;64(1):297-305. doi: 10.1002/art.30644.

  • Joffe NE, Lynch-Jordan A, Ting TV, Arnold LM, Hashkes PJ, Lovell DJ, Passo MH, Powers SW, Schikler KN, Kashikar-Zuck S. Utility of the PedsQL rheumatology module as an outcome measure in juvenile fibromyalgia. Arthritis Care Res (Hoboken). 2013 Nov;65(11):1820-7. doi: 10.1002/acr.22045.

MeSH Terms

Conditions

FibromyalgiaChronic Pain

Interventions

Cognitive Behavioral TherapyEducational Status

Condition Hierarchy (Ancestors)

Muscular DiseasesMusculoskeletal DiseasesRheumatic DiseasesNeuromuscular DiseasesNervous System DiseasesPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Behavior TherapyPsychotherapyBehavioral Disciplines and ActivitiesSocioeconomic FactorsPopulation Characteristics

Results Point of Contact

Title
Susmita Kashikar-Zuck, PhD
Organization
Cincinnati Children's Hospital Medical Center

Study Officials

  • Susmita Kashikar-Zuck, PhD

    Children's Hospital Medical Center, Cincinnati

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
phase 3
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 22, 2004

First Posted

June 23, 2004

Study Start

July 1, 2004

Primary Completion

July 1, 2010

Study Completion

July 1, 2010

Last Updated

September 20, 2017

Results First Posted

November 6, 2013

Record last verified: 2017-08

Locations